Skip to main content
. 2019 Oct 4;55(10):672. doi: 10.3390/medicina55100672
CDI Clostridium difficile infection
CMV Cytomegalovirus
DAA Direct-acting antivirals
EXPANDER Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV Negative Recipients
HCV Hepatitis C virus
HR Hazards Ratio
NAT Nucleic Acid Testing
QALY Quality Adjusted Life Years
PCR Polymerase Chain Reaction
THINKER Transplanting HCV-infected Kidneys into Negative Kidney Recipients